Success of Online Education Related to New Data in T2D Management

We sought to determine if online continuing medical education (CME) could improve the knowledge and confidence of multiple specialties related to CVOT data for T2D therapies. The CME activity was a 30-minute online video panel discussion with synchronized slides focusing on new data at ADA 2020. A repeated pairs pre-/post-assessment study design and chi-square test (P <.05 is considered significant) assessed educational effect. The activity launched June 25, 2020 and data were collected through September 3, 2020. In total, 212 PCPs and 72 D/Es were included in the analysis. Overall, there were knowledge and confidence improvements seen among all groups from pre- to post-assessment: • 23% of PCPs (P<.01) and 24% of D/Es (P<.05) improved at recognizing the benefits of SGLT2 inhibitors across the class • 20% of PCPs (P=.NS) and 17% of D/Es (P<.05) improved at identifying new data presented at a conference • 15% of PCPs (P=.NS) and 13% of D/Es (P=.NS) improved at identifying class effect of SGLT2 inhibitors on hospitalizations for heart failure • 36% of PCPs and 25% of D/Es had measurable increases in confidence in treating patients with T2D and CVD Continued educational gaps: • 62% of PCPs and 39% of D/Es failed to identify benefits of SGLT2 inhibitors across the class • 45% of PCPs and 19% of D/Es failed to recognize new data presented at a conference • 58% of PCPs and 31% of D/Es failed to identify class effect of SGLT2 inhibitors on hospitalizations for heart failure This study demonstrates the success of online CME on improving knowledge and confidence of a multi-specialty group on CVOT data. Continued gaps were identified for future educational targets.